SABA MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SABA MED
Largest movements
- Receivables within one year -€72,189
down €72,189 (-79.1%), from €91,295 to €19,106
- Profit (loss) carried forward -€70,859
down €70,859 (-99.8%), from €70,967 to €109
- Tax, wage and social debts -€8,045
no longer reported in 2025 (was €8,045)
- Contributions +€6,500
up €6,500 (+52.0%), from €12,500 to €19,000
No income-statement line moved by more than 1% of the activity.
From the 2024 result to the 2025 result
The net result is not in both sets of accounts; without it the difference cannot be explained line by line.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €91,512 | €19,109 | -€72,404 | -79.1% |
| Current assets | 29/58 | €91,512 | €19,109 | -€72,404 | -79.1% |
| Amounts receivable within one year | 40/41 | €91,295 | €19,106 | -€72,189 | -79.1% |
| Other amounts receivable | 41 | €91,295 | €19,106 | -€72,189 | -79.1% |
| Cash at bank and in hand | 54/58 | €218 | €3 | -€215 | -98.8% |
| Total equity and liabilities | 10/49 | €91,512 | €19,109 | -€72,404 | -79.1% |
| Equity | 10/15 | €83,467 | €19,109 | -€64,359 | -77.1% |
| Contributions | 10/11 | €12,500 | €19,000 | +€6,500 | +52.0% |
| Contributions outside capital | 11 | €12,500 | - | -€12,500 | |
| Other | 1109/19 | €12,500 | - | -€12,500 | |
| Profit (loss) carried forward | 14 | €70,967 | €109 | -€70,859 | -99.8% |
| Amounts payable | 17/49 | €8,045 | - | -€8,045 | |
| Amounts payable within one year | 42/48 | €8,045 | - | -€8,045 | |
| Taxes, remuneration and social security | 45 | €8,045 | - | -€8,045 | |
| Taxes | 450/3 | €8,045 | - | -€8,045 | |
| Financial charges | 65/66B | - | €859 | +€859 | |
| Recurring financial charges | 65 | - | €859 | +€859 | |
| Profit (loss) for the period before taxes | 9903 | - | -€859 | -€859 | |
| Profit (loss) for the period | 9904 | - | -€859 | -€859 | |
| Profit (loss) for the period to be appropriated | 9905 | - | -€859 | -€859 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.